BMP induced inflammation: A comparison of rhBMP-7 and rhBMP-2

Journal of Orthopaedic Research

Volumn 30, Issue 12, 2012, Pages 1985-1994

  Lee, Kwang Bok ^a,b   Taghavi, Cyrus E ^a   Murray, Samuel S ^c,d   Song, Kyung Jin ^b   Keorochana, Gun ^a   Wang, Jeffrey C ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Chonbuk National University Medical School   (South Korea)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

inflammation; MIPAV; rhBMP 2; rhBMP 7; soft tissue edema

Indexed keywords

COLLAGEN SPONGE; INTERLEUKIN 6; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT OSTEOGENIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; INFLAMMATION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SOFT TISSUE INFLAMMATION;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 7; CELL LINE; CYTOKINES; EDEMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRANULOMA; HUMANS; INFLAMMATION; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MAGNETIC RESONANCE IMAGING; MALE; RATS; RATS, INBRED LEW; RECOMBINANT PROTEINS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84867872072     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22160     Document Type: Article

References (22)

1. Benglis D, Wang MY, Levi AD., 2008. A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery. Neurosurgery 62: ONS423-ONS431.
2. Poynton AR, Lane JM., 2002. Safety profile for the clinical use of bone morphogeneticproteins in the spine. Spine 27: S40-S48.
3. Baskin DS, Ryan P, Sonntag V, et al. 2003. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSONE-SR allograft ring and the ATLANTIS anterior cervical plate. Spine 28: 1219-1225.
4. Lanman TH, Hopkins TH., 2004. Early findings in a pilot study of anterior cervical interbody fusion in which recombinant human bone morphogenetic protein 2 was used with poly (L -lactide-co- D, L -lactide) bioabsorbalble implants. Neurosurg Focus 16: 1-5.
5. Boakye M, Mummaneni PV, Garrett M, et al. 2005. Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein. J Neurosurg Spine 2: 521-525.
6. Smucker JD, Rhee JM, Singh K, et al. 2006. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine 31: 2813-2819.
7. Perri B, Cooper M, Lauryssen C, et al. 2007. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study. Spine J 7: 35-39.
8. Shields LBE, Raque GH, Glassman SD, et al. 2006. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 31: 542-547.
9. Lee KB, Taghavi CE, Song KJ, et al. 2011. Inflammatory characteristics of rhBMP-2 in vitro and in an in vivo rodent model. Spine 36: E149-E154.
10. Szczepanik AM, Funes S, Petko W, et al. 2001. IL-4, IL-10 and IL-13 modulate Ab(1-42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J Neuroimmunol 113: 49-62.
11. Tang J, Chen X, Tu W, et al. 2011. Propofol inhibits the activation of p38 through up-regulating the expression of annexin A1 to exert its anti-inflammation effect. PLoS ONE 6: e27890.
12. Taghavi CE, Lee KB, He W, et al. 2010. Bone morphogenetic protein binding peptide mechanism and enhancement of osteogenic protein-1 induced bone healing. Spine 35: 2049-2056.
13. Miyazaki M, Morishita Y, He W, et al. 2009. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats. Spine J 9: 22-30.
14. Bazin PL, Cuzzocreo JL, Yassa MA, et al. 2007. Volumetric neuroimage analysis extensions for the MIPAV software package. J Neurosci Method 165: 111-121.
15. Aube C, Moal F, Oberti F, et al. 2007. Diagnosis and measurement of liver fibrosis by MRI in bile duct ligated rats. Dig Dis Sci 52: 2601-2609.
16. Smith-Hammond CA, New KC, Pietrobon R, et al. 2004. Prospective analysis of incidence and risk factors of dysphagia in spine surgery patients. Spine 29: 1441-1446.
17. Griffith DL, Keck PC, Sampath TK, et al. 1996. Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily. PNAS 93: 878-883.
18. Shoda A, Murakami K, Ueno N., 1993. Presence of high molecular weight forms of BMP-2 in early Xenopus embryos. Growth Factors 8: 165-172.
19. Brown A, Stock G, Patel AA, et al. 2006. Osteogenic protein-1. A review of its utility in spinal applications. Biodrugs 20: 243-251.
20. Urist MR, Hay PH, Dubuc F, et al. 1969. Osteogenic competence. Clin Orthop Rel Res 64: 194-220.
21. Kawamura M, Urist MR., 1988. Human fibrin is a physiological delivery system for bone morphogenetic protein. Clin Orthop Rel Res 235: 302-310.
22. Cunningham NS, Paralkar V, Reddi HA., 1992. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor β1 mRNA expression. Proc Natl Acad Sci USA 89: 11740-11744.